298 related articles for article (PubMed ID: 26439305)
41. Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis.
Desterke C; Martinaud C; Guerton B; Pieri L; Bogani C; Clay D; Torossian F; Lataillade JJ; Hasselbach HC; Gisslinger H; Demory JL; Dupriez B; Boucheix C; Rubinstein E; Amsellem S; Vannucchi AM; Le Bousse-Kerdilès MC
Haematologica; 2015 Jun; 100(6):757-67. PubMed ID: 25840601
[TBL] [Abstract][Full Text] [Related]
42. EDA fibronectin-TLR4 axis sustains megakaryocyte expansion and inflammation in bone marrow fibrosis.
Malara A; Gruppi C; Abbonante V; Cattaneo D; De Marco L; Massa M; Iurlo A; Gianelli U; Balduini CL; Tira ME; Muro AF; Chauhan AK; Rosti V; Barosi G; Balduini A
J Exp Med; 2019 Mar; 216(3):587-604. PubMed ID: 30733282
[TBL] [Abstract][Full Text] [Related]
43. Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietin.
Wagner-Ballon O; Chagraoui H; Prina E; Tulliez M; Milon G; Raslova H; Villeval JL; Vainchenker W; Giraudier S
J Immunol; 2006 Jun; 176(11):6425-33. PubMed ID: 16709799
[TBL] [Abstract][Full Text] [Related]
44. Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
Teodorescu P; Pasca S; Jurj A; Gafencu G; Joelsson JP; Selicean S; Moldovan C; Munteanu R; Onaciu A; Tigu AB; Buse M; Zimta AA; Stiufiuc R; Petrushev B; Desmirean M; Dima D; Vlad C; Bergthorsson JT; Berce C; Ciurea S; Ghiaur G; Tomuleasa C
J Cell Mol Med; 2020 Oct; 24(19):11100-11110. PubMed ID: 32889753
[TBL] [Abstract][Full Text] [Related]
45. Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis.
Vannucchi AM; Pancrazzi A; Guglielmelli P; Di Lollo S; Bogani C; Baroni G; Bianchi L; Migliaccio AR; Bosi A; Paoletti F
Am J Pathol; 2005 Sep; 167(3):849-58. PubMed ID: 16127162
[TBL] [Abstract][Full Text] [Related]
46. P-selectin, and not E-selectin, negatively regulates murine megakaryocytopoiesis.
Banu N; Avraham S; Avraham HK
J Immunol; 2002 Oct; 169(8):4579-85. PubMed ID: 12370396
[TBL] [Abstract][Full Text] [Related]
47. Idiopathic myelofibrosis accompanied by peritoneal extramedullary hematopoiesis presenting as refractory ascites in a dog.
Rautenbach Y; Goddard A; Clift SJ
Vet Clin Pathol; 2017 Mar; 46(1):46-53. PubMed ID: 27874969
[TBL] [Abstract][Full Text] [Related]
48. Gata1 expression driven by the alternative HS2 enhancer in the spleen rescues the hematopoietic failure induced by the hypomorphic Gata1low mutation.
Migliaccio AR; Martelli F; Verrucci M; Sanchez M; Valeri M; Migliaccio G; Vannucchi AM; Zingariello M; Di Baldassarre A; Ghinassi B; Rana RA; van Hensbergen Y; Fibbe WE
Blood; 2009 Sep; 114(10):2107-20. PubMed ID: 19571316
[TBL] [Abstract][Full Text] [Related]
49. Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis.
Campanelli R; Fois G; Catarsi P; Poletto V; Villani L; Erba BG; Maddaluno L; Jemos B; Salmoiraghi S; Guglielmelli P; Abbonante V; Di Buduo CA; Balduini A; Iurlo A; Barosi G; Rosti V; Massa M;
PLoS One; 2016; 11(6):e0156990. PubMed ID: 27281335
[TBL] [Abstract][Full Text] [Related]
50. Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis.
Evrard S; Bluteau O; Tulliez M; Rameau P; Gonin P; Zetterberg E; Palmblad J; Bonnefoy A; Villeval JL; Vainchenker W; Giraudier S; Wagner-Ballon O
Blood; 2011 Jan; 117(1):246-9. PubMed ID: 20944070
[TBL] [Abstract][Full Text] [Related]
51. The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.
Uchiyama T; Kawabata H; Miura Y; Yoshioka S; Iwasa M; Yao H; Sakamoto S; Fujimoto M; Haga H; Kadowaki N; Maekawa T; Takaori-Kondo A
Cancer Med; 2015 Oct; 4(10):1558-72. PubMed ID: 26276681
[TBL] [Abstract][Full Text] [Related]
52. Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.
Ceglia I; Dueck AC; Masiello F; Martelli F; He W; Federici G; Petricoin EF; Zeuner A; Iancu-Rubin C; Weinberg R; Hoffman R; Mascarenhas J; Migliaccio AR
Exp Hematol; 2016 Dec; 44(12):1138-1155.e4. PubMed ID: 27592389
[TBL] [Abstract][Full Text] [Related]
53. TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis.
Varricchio L; Iancu-Rubin C; Upadhyaya B; Zingariello M; Martelli F; Verachi P; Clementelli C; Denis JF; Rahman AH; Tremblay G; Mascarenhas J; Mesa RA; O'Connor-McCourt M; Migliaccio AR; Hoffman R
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34383713
[TBL] [Abstract][Full Text] [Related]
54. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
[TBL] [Abstract][Full Text] [Related]
55. GATA1-defective immune-megakaryocytes as possible drivers of idiopathic pulmonary fibrosis.
Gobbo F; Zingariello M; Verachi P; Falchi M; Arciprete F; Martelli F; Peli A; Mazzarini M; Vierstra J; Mead-Harvey C; Dueck AC; Sarli G; Nava S; Sgalla G; Richeldi L; Migliaccio AR
bioRxiv; 2023 Sep; ():. PubMed ID: 37425686
[TBL] [Abstract][Full Text] [Related]
56. Heat shock protein 90 inhibitors induce cell differentiation via the ubiquitin-dependent aurora kinase A degradation in a MPLW515L mouse model of primary myelofibrosis.
Wang F; Zhang H; He B; Liu Z; Wu X; Liu Y; Xu X; Gou X; Wang H; Yang Q
Hematol Oncol; 2023 Aug; 41(3):474-486. PubMed ID: 36422297
[TBL] [Abstract][Full Text] [Related]
57. Spleens of myelofibrosis patients contain malignant hematopoietic stem cells.
Wang X; Prakash S; Lu M; Tripodi J; Ye F; Najfeld V; Li Y; Schwartz M; Weinberg R; Roda P; Orazi A; Hoffman R
J Clin Invest; 2012 Nov; 122(11):3888-99. PubMed ID: 23023702
[TBL] [Abstract][Full Text] [Related]
58. FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis.
Desterke C; Bilhou-Nabéra C; Guerton B; Martinaud C; Tonetti C; Clay D; Guglielmelli P; Vannucchi A; Bordessoule D; Hasselbalch H; Dupriez B; Benzoubir N; Bourgeade MF; Pierre-Louis O; Lazar V; Vainchenker W; Bennaceur-Griscelli A; Gisslinger H; Giraudier S; Le Bousse-Kerdilès MC; ; ;
Cancer Res; 2011 Apr; 71(8):2901-15. PubMed ID: 21487043
[TBL] [Abstract][Full Text] [Related]
59. Assessment of sites of marrow and extramedullary hematopoiesis by hybrid imaging in primary myelofibrosis patients.
Ojeda-Uribe M; Morel O; Ungureanu C; Desterke C; Le Bousse-Kerdilès MC; Boulahdour H
Cancer Med; 2016 Sep; 5(9):2378-84. PubMed ID: 27518041
[TBL] [Abstract][Full Text] [Related]
60. Interesting splenic histology in a patient with advanced myelofibrosis.
Chandler I; DeLord C
Br J Haematol; 2002 Jul; 118(1):1. PubMed ID: 12100123
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
